We observe overall survival effects of cytosolic carbonic anhydrases (Fig. 3E-H) only in HER2-enriched breast cancer where high expression levels associate with improved survival (HR = 0.753, Fig. 3G). The gene discussed is ERBB2; the disease is breast cancer.